Does Wisconsin Medicaid Cover Wegovy? Eligibility and Authorization

Yes, Wisconsin Medicaid does cover Wegovy, but only with prior authorization and under strict rules. ForwardHealth, the agency that runs the state’s Medicaid and BadgerCare Plus pharmacy benefit, will approve Wegovy for weight management when a member meets BMI and clinical criteria, and it caps that use at two 12-month treatment courses per lifetime. Coverage for Wegovy’s cardiovascular and liver-disease indications runs on a separate track with no lifetime limit.

Who Qualifies for Weight-Management Coverage

ForwardHealth does not require step therapy. Members do not have to try and fail other weight-loss drugs before Wegovy can be approved.¹

For adults 18 and older, the BMI thresholds are:

BMI of 30 or higher, with no additional conditions required beyond the general rules below.
BMI of 27 to 29.9, with at least two of these risk factors currently being treated: high cholesterol, high blood pressure, sleep apnea, type 2 diabetes, or cardiovascular disease.

Adolescents aged 12 to 17 qualify if their BMI is at or above the 95th percentile for their age and sex. This pediatric pathway was added in a November 2025 revision to the prior authorization form, which expanded access beyond the earlier adults-only policy.²

Every member, regardless of age, also has to meet these conditions:

Not pregnant or nursing.
No history of an eating disorder such as anorexia, bulimia, or binge eating disorder.
No medical or medication contraindications, as judged by the prescriber.
Active participation in a structured weight-loss plan involving nutritional counseling, exercise, or a calorie-restricted diet for at least the past six months, and continued participation while on the medication.³

Members are limited to one anti-obesity drug at a time. Wegovy cannot be combined with Zepbound or Saxenda.

How Prior Authorization Gets Submitted

A pharmacy cannot dispense Wegovy without an approved prior authorization on file. The prescriber completes the Prior Authorization Drug Attachment for Anti-Obesity Drugs (Form F-00163) and submits it with a Prior Authorization Request Form through the ForwardHealth Portal, by fax, by mail, or by calling the Drug Authorization and Policy Override Center.⁴

The form documents height, weight, BMI, diagnosis code, goal weight, and confirmation that every clinical criterion is met. The prescriber signs, dates, and keeps a copy of the form and supporting records.²

How Long Coverage Lasts

Weight-management coverage runs in phases with hard caps:

Initial approval lasts up to 183 days, roughly six months.
Renewal for another 183 days requires that the member has lost at least 5% of baseline weight and is on an appropriate maintenance dose.
The maximum for a single course is 12 continuous months.
After finishing a course, or after failing to hit the 5% weight-loss goal, a six-month waiting period must pass before a new request can be submitted.
ForwardHealth allows only two weight-loss treatment courses with Wegovy per member’s lifetime. Requests beyond that are treated as noncovered services with no appeal rights.³

One more cutoff: if a member’s BMI drops below 24 at any point during treatment, the prior authorization will not be renewed.³

These limits are enforced strictly. In a December 2024 administrative decision, an administrative law judge upheld a Wegovy denial because the member had not completed the six-month waiting period after finishing a 12-month course, noting that the agency cannot grant equitable exceptions to the clinical criteria.⁵

Cardiovascular and Liver-Disease Indications

Wegovy has FDA-approved uses beyond weight loss, and ForwardHealth covers two of them on a separate, more flexible pathway. Neither carries the two-course lifetime limit or the BMI-below-24 cutoff that apply to weight-management coverage.⁶

Reducing Cardiovascular Risk

Members with established cardiovascular disease (a history of heart attack, stroke, or peripheral arterial disease) and a BMI of 27 or higher can qualify for Wegovy specifically to lower their risk of major cardiovascular events. The initial approval is 183 days, the first renewal is another 183 days, and subsequent renewals extend to 365 days. Renewals require documentation that the member is following a reduced-calorie diet and physical activity plan and is on a 1.7 mg or 2.4 mg maintenance dose.⁷

Treating MASH

Wegovy is also covered for members with noncirrhotic MASH (formerly NASH) at fibrosis stages F2 to F3, confirmed by biopsy or noninvasive testing such as FibroScan. The prescription must come from a liver specialist such as a gastroenterologist or hepatologist, and the member must not have had significant alcohol consumption in the preceding year.⁶

What Members Pay

Wegovy is a brand-name drug, so the standard Medicaid copay of $3 per fill applies for most adult members. No member pays more than $12 in total copayments to any single provider in a calendar month.⁸

Several groups are exempt from all copayments: children under 19, American Indian and Alaska Native members, nursing home residents, hospice patients, and Wisconsin Well Woman Medicaid enrollees. Federal law also caps combined Medicaid premiums and copayments at 5% of monthly household income.⁸

BadgerCare Plus, Managed Care, and Dual Eligibility

BadgerCare Plus members are covered under the same ForwardHealth criteria described above.⁹¹⁰¹¹

If you have both Medicare and Medicaid, anti-obesity drugs including Wegovy go through your Medicare Part D plan as the primary payer. The same ForwardHealth prior authorization criteria still apply.³

If Your Prior Authorization Is Denied

When a Wegovy request is denied, the member (not the prescriber) has the right to request a fair hearing through the Division of Hearings and Appeals. File within 45 days of the date on the Notice of Appeal Rights letter.¹²

You can file by mail, by phone at 608-266-7709, or by submitting a Request for Fair Hearing form. Written notice of the hearing arrives at least 10 days in advance, and you may bring witnesses, legal representation, or family members. If you request a hearing before the denial’s effective date, benefits may continue during the appeal, though you may have to repay the cost if the denial is upheld.¹³

One limit is worth knowing before you file. Denials based on the two-course lifetime cap are classified as noncovered services, and there are no appeal rights for those. The fair-hearing process is available only when a denial turns on the clinical criteria for an individual request, not the program’s structural caps.⁵

1
ForwardHealth. Prior Authorization Drug Attachment for Anti-Obesity Drugs
2
Wisconsin Department of Health Services. Prior Authorization Drug Attachment for Anti-Obesity Drugs, F-00163
3
ForwardHealth. Anti-Obesity Drugs
4
Wisconsin Department of Health Services. Prior Authorization Drug Attachment for Anti-Obesity Drugs Instructions, F-00163
5
Elder Law of Wisconsin. MPA 215583
6
Pharmacy Society of Wisconsin. ForwardHealth Anti-Obesity Drug Coverage Toolkit
7
ForwardHealth. Anti-Obesity Drugs – Coverage Details
8
ForwardHealth. Copayments
9
George Washington University Milken Institute School of Public Health. Wisconsin Medicaid Obesity Coverage Snapshot
10
MHS Health Wisconsin. Pharmacy
11
My Choice Wisconsin. Pharmacy Drug Coverage Info
12
ForwardHealth. Appeals
13
Wisconsin Department of Health Services. Your Right to a Fair Hearing